Clinical Trial Update: Hydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for hydroxychloroquine in mastocytosis patients across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mastocytosis

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Mastocytosis | Phase 2, Phase 3 | Status: UNKNOWN